Spinális izomatrófia (SMA): vizsgálatok itt: Egyesült Államok
9 of 17 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Where
- Baltimore, Boston, Chicago, Columbia, Flower Mound, Hartford, Hillsborough, Houston, Iowa City, Kissimmee, Little Rock, New York, Norfolk, Philadelphia, San Diego, Stanford
- Életkor
- 5 év to 17 év
- People
- 60 worldwide
- Run by
- argenx
See details and how to joinNCT07287982 · EU 2025-523496-32-00 - 3. fázisTaking peopleA Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
- Where
- Boston, Norfolk, Palo Alto
- Életkor
- 15 év to 60 év
- People
- 90 worldwide
- Run by
- Biogen
See details and how to joinNCT07444476 - No phaseTaking peopleStudy of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
- Where
- Austin, Baltimore, Boston, Charlottesville, Chicago, Cleveland, Grand Rapids, Hershey, Houston, New York, Norfolk, Orange, Orlando, Palo Alto, Philadelphia, Phoenix, San Diego
- Életkor
- 3 év and over
- People
- 90 worldwide
- Run by
- Alcyone Therapeutics, Inc
See details and how to joinNCT05866419 - 4. fázisTaking peopleASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
- Where
- Boston, Columbus, Little Rock, New York, Philadelphia, Stanford
- Életkor
- 2 év to 100 év
- People
- 36
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07448610 - 3. fázisTaking peopleA Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Where
- Chicago, Flower Mound, Norfolk
- Életkor
- 0 nap to 42 nap
- People
- 30 worldwide
- Run by
- Biogen
See details and how to joinNCT07221669 · EU 2025-524054-34-00 - No phaseTaking peopleHABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
- Where
- New York
- Életkor
- 5 év to 17 év
- People
- 20
- Run by
- Teachers College, Columbia University
See details and how to joinNCT07488338 - 3. fázisTaking peopleA Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
- Where
- Flower Mound
- Életkor
- 0 nap to 7 hónap
- People
- 42 worldwide
- Run by
- Biogen
See details and how to joinNCT07444450 · EU 2025-523857-32-00 - 2. fázisTaking peopleA Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- Where
- Atlanta, Aurora, Dallas, Flower Mound, Fort Worth, Grand Rapids, Houston, Iowa City, Orange, Palo Alto, Philadelphia, Phoenix
- Életkor
- Up to 2 év
- People
- 52 worldwide
- Run by
- Scholar Rock, Inc.
See details and how to joinNCT07047144 - 1. fázisTaking peopleA Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Where
- Boston, Charlottesville, Chicago, Grand Rapids, Hershey, Houston, Norfolk, Orange, Orlando, Palo Alto, Philadelphia, Phoenix
- Életkor
- 3 év and over
- People
- 78 worldwide
- Run by
- Biogen
See details and how to joinNCT06555419 · EU 2024-514239-21-00